Fabrication a novel ethylenediamine sulfonamide polymer resin and graphene-modified carbon paste electrodes for simultaneous determination of anti-HBV drugs entecavir and tenofovir in dosage form by differential pulse voltammetry
Abstract
Keywords
References
- [1] Asran AM, Mohamed MA, Ahmed N, Banks CE,Allam NK. An innovative electrochemical platform for the sensitive determination of the hepatitis B inhibitor Entecavir with ionic liquid as a mediator. J Mol Liq. 2020; 302: 112498. https://doi.org/10.1016/j.molliq.2020.112498
- [2] Guvenir M, Arikan A.Hepatitis B Virus: From Diagnosis to Treatment. Pol J Microbiol. 2020; 69(4): 391-399. https://doi.org/10.33073/pjm-2020-044
- [3] Yeh ML, Huang CF, Huang CI, Holmes JA, Hsieh MH, Tsai YS, Liang PC, Tsai PC, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chung RT, Yu ML. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection. J Hepatol. 2020; 73(1): 62-71. https://doi.org/10.1016/j.jhep.2020.01.027
- [4] Pawlotsky JM, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, Marra F, Puoti M, Wedemeyer H. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020; 73(5): 1170-1218. https://doi.org/10.1016/j.jhep.2020.08.018
- [5] Huang P, Wang Y, Yue M, Ge Z, Xia X, Jeyarajan AJ, Holmes JA, Yu R, Zhu C, Yang S, Lin W, Chung RT. The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis. Liver Int. 2021; 41(10): 2341-2357. https://doi.org/10.1111/liv.14976
- [6] Chien RN, Liaw YF. Current trend in antiviral therapy for chronic hepatitis B. Viruses. 2022; 14(2):434. https://doi.org/10.3390/v14020434
- [7] Shiffman ML. Approach to the patient with chronic hepatitis B and decompensated cirrhosis. Liver Int. 2020; 40(S1):22-26. https://doi.org/10.1111/liv.14359
- [8] Lim YS, Seto WK, Kurosaki M, Fung S, Kao JH, Hou J, Gordon SC, Flaherty JF, Yee LJ, Zhao Y, Agarwal K, Lampertico P. Review article: Switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data. Aliment Pharmacol Ther. 2022; 55(8): 921-943. https://doi.org/10.3390/v12090998
Details
Primary Language
English
Subjects
Pharmaceutical Analytical Chemistry
Journal Section
Research Article
Authors
Adel Asfoor
This is me
0000-0003-3936-7144
Türkiye
Zeynep Aydoğmuş
*
0000-0001-7784-0129
Türkiye
Bahire Senkal
0000-0002-1616-6828
Türkiye
Publication Date
June 28, 2025
Submission Date
June 2, 2023
Acceptance Date
August 7, 2023
Published in Issue
Year 2024 Volume: 28 Number: 3